Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

First phase II monotherapy study of 17-AAG begins

July 21, 2004

Telomerase inhibitor inhibits glioblastoma growth in vivo

July 21, 2004

Tyropeptin A analogues with antitumor activity disclosed in patent

July 20, 2004

TGF-beta inhibitor claimed in Lilly patent

July 20, 2004

Aldara receives approval for superficial basal cell carcinoma

July 20, 2004

CancerVax licenses rights to SAI product candidates targeting EGFR

July 20, 2004

Small molecule VEGF antagonist inhibits tumor growth in vivo

July 20, 2004

Phosphotidylinositol 3-kinase inhibitors described by Chiron

July 19, 2004

Lilly claims TGF-beta signal transduction inhibitors

July 19, 2004

Phase I trial for new formulation of 17-AAG in multiple myeloma

July 19, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
CINP 2026: organoids reveal autism and addiction mechanisms
BioWorld Science
At the 2026 World Congress of Neuropsychopharmacology (CINP), held in Glasgow June 26-29, 2026, researchers from Japan’s National Center of Neurology and...
Deerfield-backed Boulevard, Metis pen $1.6B trispecific TCE deal
BioWorld
A U.S. biotechnology company founded by Deerfield Management Company L.P. licensed exclusive rights to Metis Techbio Co. Ltd.’s preclinical trispecific T-cell...